781 related articles for article (PubMed ID: 11705127)
21. Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom.
Stewart S; McMurray JJ; Hebborn A; Coats AJ; Packer M;
Int J Cardiol; 2005 Apr; 100(1):143-9. PubMed ID: 15820297
[TBL] [Abstract][Full Text] [Related]
22. The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.
Wilson EC; McKeen ES; Scuffham PA; Brown MC; Wylie K; Hackett G
Pharmacoeconomics; 2002; 20(13):879-89. PubMed ID: 12381240
[TBL] [Abstract][Full Text] [Related]
23. Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department.
Nageswaran A; Kinghorn GR; Shen RN; Priestley CJ; Kyi TT
Int J STD AIDS; 1995; 6(5):336-44. PubMed ID: 8547414
[TBL] [Abstract][Full Text] [Related]
24. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
25. A cost analysis of monoplace hyperbaric oxygen therapy with and without recirculation.
Treweek S; James PB
J Wound Care; 2006 Jun; 15(6):235-8. PubMed ID: 16802558
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
[TBL] [Abstract][Full Text] [Related]
27. Costs of treating lower respiratory tract infections.
Monte SV; Paolini NM; Slazak EM; Schentag JJ; Paladino JA
Am J Manag Care; 2008 Apr; 14(4):190-6. PubMed ID: 18402511
[TBL] [Abstract][Full Text] [Related]
28. The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK.
Turner DA; Shaw C; McGrother CW; Dallosso HM; Cooper NJ;
BJU Int; 2004 Jun; 93(9):1246-52. PubMed ID: 15180616
[TBL] [Abstract][Full Text] [Related]
29. Pinch grafting in hospital and primary care: a cost analysis.
Oien RF; Håkansson A; Ahnlide I; Bjellerup M; Hansen BU; Borgquist L
J Wound Care; 2001 May; 10(5):164-9. PubMed ID: 12964324
[TBL] [Abstract][Full Text] [Related]
30. The current cost of heart failure to the National Health Service in the UK.
Stewart S; Jenkins A; Buchan S; McGuire A; Capewell S; McMurray JJ
Eur J Heart Fail; 2002 Jun; 4(3):361-71. PubMed ID: 12034163
[TBL] [Abstract][Full Text] [Related]
31. Costs and concentration of cancer care: evidence for pancreatic, oesophageal and gastric cancers in National Health Service hospitals.
Bachmann M; Peters T; Harvey I
J Health Serv Res Policy; 2003 Apr; 8(2):75-82. PubMed ID: 12820668
[TBL] [Abstract][Full Text] [Related]
32. Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland.
Keitel K; Alcoba G; Lacroix L; Manzano S; Galetto-Lacour A; Gervaix A
Swiss Med Wkly; 2014; 144():w13925. PubMed ID: 24706389
[TBL] [Abstract][Full Text] [Related]
33. Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospitalisation--an Italian perspective.
Allegra C
Curr Med Res Opin; 2003; 19(8):761-9. PubMed ID: 14687448
[TBL] [Abstract][Full Text] [Related]
34. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review.
Halpern MT; Higashi MK; Bakst AW; Schmier JK
J Manag Care Pharm; 2003; 9(4):353-9. PubMed ID: 14613454
[TBL] [Abstract][Full Text] [Related]
35. Consultant supported intermediate care--a model for remote and island hospitals.
Godden DJ; Ludbrook A; McIntyre L; Perez JG; Harvey R
Rural Remote Health; 2004; 4(2):276. PubMed ID: 15884998
[TBL] [Abstract][Full Text] [Related]
36. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.
Bassi A; Dodd S; Williamson P; Bodger K
Gut; 2004 Oct; 53(10):1471-8. PubMed ID: 15361497
[TBL] [Abstract][Full Text] [Related]
37. COPD management costs according to the frequency of COPD exacerbations in UK primary care.
Punekar YS; Shukla A; Müllerova H
Int J Chron Obstruct Pulmon Dis; 2014; 9():65-73. PubMed ID: 24426781
[TBL] [Abstract][Full Text] [Related]
38. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
[TBL] [Abstract][Full Text] [Related]
39. Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial.
Creed F; Mbaya P; Lancashire S; Tomenson B; Williams B; Holme S
BMJ; 1997 May; 314(7091):1381-5. PubMed ID: 9161310
[TBL] [Abstract][Full Text] [Related]
40. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.
Guest JF; Hart WM; Cookson RF
Pharmacoeconomics; 1998 Sep; 14(3):285-97. PubMed ID: 10186467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
